Sean Ellis

Sean Ellis is a declared insider of Entera Bio Ltd. (board member), with filings sourced from SEC (Form 4). The record holds 11 filings, for trades running from 18 January 2022 to 7 August 2026.

The open-market record is one-sided, with 6 purchases worth €116k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 5 share grants. 2026 to date brings 2 purchases and no sales.

The median purchase comes to €20k. Clusters matter here: 5 out of 6 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 7 August 2026, the filings show a share grant in Entera Bio Ltd. The most recent open-market purchase was published on 9 March 2026, 223 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.